Oncomed Pharma
(OMED)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2012 | 06-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -17,940 | -14,285 | -15,030 | -27,010 |
| Depreciation Amortization | 988 | 650 | 940 | 2,560 |
| Accounts receivable | N/A | -500 | N/A | N/A |
| Other Working Capital | -8,241 | -10,718 | 1,940 | 28,090 |
| Other Operating Activity | 607 | 895 | 870 | 860 |
| Operating Cash Flow | $-24,586 | $-23,958 | $-11,280 | $4,500 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 33,696 | 25,687 | N/A | N/A |
| PPE Investments | -660 | -610 | -2,240 | -840 |
| Other Investing Activity | 0 | 0 | 9,640 | -700 |
| Investing Cash Flow | $33,036 | $25,077 | $7,400 | $-1,540 |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | -346 | -202 | N/A | N/A |
| Common Stock Issued | 146 | 123 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -680 | -700 |
| Financing Cash Flow | $-200 | $-79 | $-680 | $-700 |
| Beginning Cash Position | 11,785 | 11,785 | 16,340 | 14,080 |
| End Cash Position | 20,035 | 12,825 | 11,780 | 16,340 |
| Net Cash Flow | $8,250 | $1,040 | $-4,560 | $2,250 |
| Free Cash Flow | ||||
| Operating Cash Flow | -24,586 | -23,958 | -11,280 | 4,500 |
| Capital Expenditure | -660 | -610 | N/A | N/A |
| Free Cash Flow | -25,246 | -24,568 | -11,280 | 4,500 |